To investigate safety of accelerated corneal crosslinking during the first postoperative month.
In this retrospective study, 76 eyes of 60 patients with verified progressive keratectasia were enrolled in this study and followed for 1 month after accelerated CXL (18 mW/cm2 for 5 min, radiant exposure 5.4 J/cm2) (A-CXL(5*18)). Preoperatively, objective refraction, slit lamp inspection, and corneal tomography were performed. Early postoperative slit lamp examinations were performed on days 1 and 4. At 1 month, objective refraction, slit lamp inspection, and corneal tomography were performed.
Gender distribution was m:f = 55:21, OD:OS was 40:36, and the average age was 26.5 ± 8.6 years at surgery. Only 71 of the 76 eyes completed the 1-month follow-up, indicating a dropout rate of 6.6%. In 7.0% (n = 5), sterile infiltrates were observed; 5.6% of eyes (n = 4) showed delayed epithelial healing (> 4 days) in 2.8% (n = 2); an infection occurred and in 1 eye (1.4%), a stromal scar was detected; no other complications, neither a loss of two or more Snellen lines at 1 month postoperatively, were observed. As a risk factor for sterile infiltrates, thin preoperative pachymetry could be identified (p = 0.027).
This study revealed no difference in early postoperative safety between CXL using 18 mW/cm2 and standard corneal CXL. Thinner preoperative pachymetry could be identified predicting a higher rate of postoperative sterile infiltrates.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Seiler T, Spoerl E, Huhle M, Kamouna A (1996) Conservative therapy of keratoconus by enhancement of collagen cross-links. Invest Ophthalmol Vis Sci 37:1017
Spoerl E, Huhle M, Kasper M, Seiler T (1997) Artificial stiffening of the cornea by induction of intrastromal cross-links. Ophthalmologe 94:902–906
Koller T, Mrochen M, Seiler T (2009) Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 35(8):1358–1362
Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T (2006) Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg 32(5):837–845
Raiskup F, Theuring A, Pillunat LE, Spoerl E (2015) Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg 41(1):41–46
Seiler TG, Schmidinger G, Fischinger I, Koller T, Seiler T (2013) Complications of corneal cross-linking. Ophthalmologe 110(7):639–644
Mazzotta C, Traversi C, Paradiso AL, Latronico ME, Rechichi M (2014) Pulsed light accelerated crosslinking versus continuous light accelerated crosslinking: one-year results. J Ophthalmol 2014:604731
Mita M, GOt W, Tomita M (2014) High-irradiance accelerated collagen crosslinking for the treatment of keratoconus: six-month results. J Cataract Refract Surg 40(6):1032–1040
Ehmke T, Seiler TG, Fischinger I, Ripken T, Heisterkamp A, Frueh BE (2016) Comparison of corneal riboflavin gradients using dextran and HPMC solutions. J Refract Surg 32(12):798–802
Chow VW, Chan TC, Yu M, Wong VW, Jhanji V (2015) One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus. Sci Rep 5:14425
Hashemi H, Fotouhi A, Miraftab M, Bahrmandy H, Seyedian MA, Amanzadeh K, Heidarian S, Nikbin H, Asgari S (2015) Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg 41(3):533–540
Tomita M, Mita M, Huseynova T (2014) Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg 40(6):1013–1020
Koller T, Iseli HP, Hafezi F, Vinciguerra P, Seiler T (2009) Scheimpflug imaging of corneas after collagen cross-linking. Cornea 28(5):510–515
Kymionis GD, Grentzelos MA, Kankariya VP, Liakopoulos DA, Portaliou DM, Tsoulnaras KI, Karavitaki AE, Pallikaris AI (2014) Safety of high-intensity corneal collagen crosslinking. J Cataract Refract Surg 40(8):1337–1340
Gatzioufas Z, Richoz O, Brugnoli E, Hafezi F (2013) Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg 29(12):846–848
Lam FC, Georgoudis P, Nanavaty MA, Khan S, Lake D (2014) Sterile keratitis after combined riboflavin-UVA corneal collagen cross-linking for keratoconus. Eye 28(11):1297–1303
Raiskup F, Hoyer A, Spoerl E (2009) Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 25(9):S824–S828
Çerman E, Özcan DÖ, Toker E (2017) Sterile corneal infiltrates after corneal collagen cross-linking: evaluation of risk factors. Acta Ophthalmol 95:199–204
Shetty R, Pahuja NK, Nuijts RM, Ajani A, Jayadev C, Sharma C, Nagaraja H (2015) Current protocols of corneal collagen cross-linking: visual, refractive, and tomographic outcomes. Am J Ophthalmol 160(2):243–249
Chan TC, Chow VW, Jhanji V, Wong VW (2015) Different topographic response between mild to moderate and advanced keratoconus after accelerated collagen cross-linking. Cornea 34(8):922–927
Raiskup F, Spoerl E (2013) Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. The ocular surface 11(2):65–74
Richoz O, Hammer A, Tabibian D, Gatzioufas Z, Hafezi F (2013) The biomechanical effect of corneal collagen cross-linking (CXL) with riboflavin and UV-A is oxygen dependent. Translational Vision Science & Technology 2(7):6
Kymionis GD, Tsoulnaras KI, Grentzelos MA, Plaka AD, Mikropoulos DG, Liakopoulos DA, Tsakalis NG, Pallikaris IG (2014) Corneal stroma demarcation line after standard and high-intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg 40(5):736–740
Brittingham S, Tappeiner C, Frueh BE (2014) Corneal cross-linking in keratoconus using the standard and rapid treatment protocol: differences in demarcation line and 12-month outcomes. Invest Ophthalmol Vis Sci 55(12):8371–8376
Hammer A, Richoz O, Arba Mosquera S, Tabibian D, Hoogewoud F, Hafezi F (2014) Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci 55(5):2881–2884
Seiler TG, Fischinger I, Senfft T, Schmidinger G, Seiler T (2014) Intrastromal application of riboflavin for corneal crosslinking. Invest Ophthalmol Vis Sci 55(7):4261–4265
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers’ bureaus, membership, employment, consultancies, stock ownership or other equity interest, and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name the institution/committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study, formal consent is not required.
Electronic supplementary material
About this article
Cite this article
Fischinger, I., Seiler, T.G., Santhirasegaram, K. et al. Corneal crosslinking (CXL) with 18-mW/cm2 irradiance and 5.4-J/cm2 radiant exposure—early postoperative safety. Graefes Arch Clin Exp Ophthalmol 256, 1521–1525 (2018). https://doi.org/10.1007/s00417-018-3978-9
- Corneal crosslinking
- Accelerated crosslinking
- 18 mW
- Sterile infiltrate